Evidence map›Paper›PMID 42056501›Full record

ArticleGene therapy2026

AAV2 capsid clearance and neuronal trafficking dynamics in the central nervous system.

Thanvi Gullapalli, Jake W Willows, Ahmad Karkhah, Vikas Munjal, Abigail Nimmo, Kaya E Ceyhan, Meika Travis, Allison O'Brien, Matthew T Rocco, Anitvir S Taunque and 2 more

Abstract read
In one paragraph

Article in Gene therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Thanvi GullapalliUndergraduate Research Program, The Ohio State University, Columbus, OH, USA.
Jake W WillowsDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Ahmad KarkhahDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Vikas MunjalDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.ORCID 0000-0001-5179-9164
Abigail NimmoDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.ORCID 0009-0007-5025-7540
Kaya E CeyhanDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Meika TravisDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.ORCID 0000-0001-6724-9925
Allison O'BrienDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Matthew T RoccoDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Anitvir S TaunqueDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.ORCID 0009-0007-8769-1439
Kristy L TownsendDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA.
Lluis SamaranchDepartment of Neurological Surgery, The Ohio State University, Columbus, OH, USA. Lluis.Samaranch@osumc.edu.ORCID 0000-0001-8151-473X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adeno-associated virus serotype 2 (AAV2) remains one of the most common vectors for CNS gene delivery. Yet, its long-term intraparenchymal trafficking and the relationship between capsid persistence and transgene expression remain poorly understood. In this study, we tracked the spatial and temporal patterns of AAV2 following direct striatal infusion in rats, analyzing tissue at 3 days, 3 weeks, 12 weeks, 30 weeks, and 67 weeks after injection. Using immunofluorescence for the human aromatic L-amino acid decarboxylase (AADC) transgene and an epitope detecting intact AAV2 capsids (A20), we mapped capsid localization, clearance, and axonal transport over more than a year. Following direct striatal infusion, AAV2 capsids rapidly localized to striatal neurons, with early accumulation in the substantia nigra pars reticulata (SNpr) detectable by 3 days post-infusion, but without evidence of nigral neuron transduction. Transgene expression increased over time and peaked locally at 12 weeks, with a delayed yet robust AADC signal in striatonigral terminals by 30 weeks. By 67 weeks, capsid signal was minimal while AADC expression remained stable. These findings clarify the long-term dynamics of AAV2 distribution, capsid persistence, and axonal transport in the adult brain, informing our understanding of vector behavior and durability following intraparenchymal AAV2 gene delivery.

Indexed as

CapsidDependovirusGenetic VectorsNeuronsParvovirinaeAnimalsAromatic-L-Amino-Acid DecarboxylasesAxonal TransportCorpus StriatumGenetic TherapyGene Transfer TechniquesHumansMaleRatsRats, Sprague-DawleySubstantia NigraAromatic-L-Amino-Acid Decarboxylases

Identifiers

PMID42056501
PMCPMC13585552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.